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Background
The World Health Organisation (WHO) estimate that 170
million individuals worldwide are infected with hepatitis
C virus (HCV). However the prevalence of HCV infection
varies throughtout the world. HCV is transmitted prima-
rily through blood or blood products or contact with
infected tissue (blood transfusion intravenous immu-
noglobulins, intavenous drug abuse and tissue trans-
plant). Since hepatitis C is a prevntable disease, accurate
description of the prevalence and risk factors for the dis-
ease is a pre-requisite for prevention. This study is of pub-
lic health importance as the National Transfusion Service
has no policy to screen donated units of blood for hepati-
tis C. This is so due to the non availability of supporting
epidemiological data and prohibitive costs of the HCV
testing kits.
Materials and methods
This was a cross-sectional study of 1600 regular health
blood donors. These donors underwent a routine blood
donor selection process. Blood sample of 5–8 mls was col-
lected into a labelled vacutainer. Blood was allowed to
clot, after centrifuging 2 mls of serum was stored at -20
degrees celcius for further analysis for confirmation of
antibodies to HCV. Serum samples were also analysed for
hepatitis B (HBV), Syphilis and HIV 1/2. All antibodies to
HCV were determined using ELISA Abbott murex (version
4.0) which has 99% sensitivity and 99.9% specificity. Sta-
tistical analysis was performed using EPI Info version 6.
Prevalence of HIV-HCV at 95% confidence interval (CI)
were calculated. Chi-squared analysis was done to test for
5% level of significance. A p-value of less than 0.05 was
considered significant. Fisher's test-2 tail probability was
used to determine for the association between factors
when the expected frequency was less than 5. Seropositve
samples were not confirmed using molecular methods
due to limited resources
Results
The median age (Q1, Q3) of the blood donors was 31
(22,46) and 56% of them were male. ELISA assay was pos-
itive for 28 samples in the studied population yielding an
overall prevalence of 1% (95% CI 0.7–1.5%). There was
no dual infection for HBV and HCV. 1.2 % Anti-HCV indi-
viduals were also positive for HIV1/2. 1.7 % individuals
tested positive for syphilis as well as positive to anti-HCV.
No association was detected between age and seropositive
status (p = 1.000). There was 18% risk of acquring infec-
tion from blood transfusion (RR = 1.18, 0.78<RR<1.79).
Conclusion
Considering the nature of the population studied the
prevalence of HIV-HCV co-infection of 1.2% is high.
Screening all donated blood for HCV must be mandatory.
There is also need to carry out a study of HCV co-infetion
in patients living with HIV/AIDS since anaemia of chronic
illness is a common trigger for blood transfusion in this
group.
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